Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Increased serum PIVKA-II levels in hyperthyroidism].

M Morimoto1, K Takeda, E Ohara

  • 1Clinical Laboratory, Kochi Medical School, Nankoku 783-8505.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regression of rectal MALT lymphoma after antibiotic treatment in a patient negative for Helicobacter pylori.

Clinical journal of gastroenterology·2015
Same author

[Increased serum soluble Fas ligand in hyperthyroid Graves' disease].

Rinsho byori. The Japanese journal of clinical pathology·1999
Same author

[An effective case of arterial infusion therapy of low-dose CDDP and continuous 5-FU for isolated hepatic recurrence of gastric carcinoma].

Gan to kagaku ryoho. Cancer & chemotherapy·1999
Same author

Identification of stable RNA hairpins causing band compression in transcriptional sequencing and their elimination by use of inosine triphosphate.

Gene·1998
Same author

Recognition sites of 3'-OH group by T7 RNA polymerase and its application to transcriptional sequencing.

The Journal of biological chemistry·1998
Same author

Evidence that [3H]glutamate binding sites are masked by biologically relevant endogenous factor on cell membranes of frog spinal cord.

Brain research·1992

Serum protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels are elevated in hyperthyroidism. PIVKA-II concentrations decrease with hyperthyroid treatment, suggesting a link between thyroid hormone and PIVKA-II.

Area of Science:

  • Endocrinology
  • Oncology
  • Biochemistry

Context:

  • Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is a recognized tumor marker for hepatocellular carcinoma.
  • Previous reports suggest elevated PIVKA-II in hyperthyroid patients without liver disease, indicating a potential non-hepatic influence.

Purpose:

  • To investigate the relationship between thyroid hormone levels and serum PIVKA-II concentrations.
  • To evaluate PIVKA-II levels across different thyroid disease states.

Summary:

  • Serum PIVKA-II concentrations were significantly higher in patients with hyperthyroidism compared to those with hypothyroidism and healthy controls.
  • PIVKA-II levels decreased in hyperthyroid patients following treatment (antithyroid drugs or isotope therapy), correlating with reduced serum FT4 levels.

Related Experiment Videos

  • No significant difference in PIVKA-II was observed between Hashimoto disease, Graves' disease, and healthy subjects.

    • Impact:

    • These findings suggest that hyperthyroidism, not just liver disease, can influence PIVKA-II levels.
    • Further in vivo research is warranted to elucidate the precise mechanism by which thyroid hormones affect PIVKA-II production or clearance.